On October 24, Porton Pharma Solutions announced a strategic partnership with Shanghai Yinosi Biotechnology Co., Ltd. in Shanghai. Ju Nianfeng, the director and general manager of Porton Pharma Solutions, stated that this cooperation with Yinosi is another important step for Porton Pharma Solutions in terms of resource sharing and model innovation. Yinosi has been deeply involved in the field of innovative drug non-clinical research services for many years. Combining Yinosi's rich experience and resources in innovative drug CDMO with Porton's will further enhance Porton Pharma Solutions' service capabilities and efficiency, accelerating the new drug development process.